Prognostic Value of Lipoprotein (a) in Japanese Patients with Acute Coronary Syndrome Surviving Primary Percutaneous Coronary Intervention to Discharge
Randomized trial investigates lipoprotein(a) as a prognostic factor in Japanese patients with acute coronary syndrome, suggesting implications for secondary prevention strategies.
Key Points
This research aims to clarify the prognostic value of lipoprotein(a) in Japanese patients with acute coronary syndrome after percutaneous coronary intervention.
Analyzed data from Japanese patients with acute coronary syndrome undergoing primary percutaneous coronary intervention.
Included early in-hospital deaths to assess the accurate prognostic significance of lipoprotein(a).
Findings indicate a potential association between elevated lipoprotein(a) levels and increased risk of adverse outcomes.
Demonstrated inconsistent results in the prognostic value of lipoprotein(a) specific to the Japanese population.